Cargando…
Rapid Processing and Drug Evaluation in Glioblastoma Patient-Derived Organoid Models with 4D Bioprinted Arrays
Glioblastoma is the most common and deadly primary brain malignancy. Despite advances in precision medicine oncology (PMO) allowing the identification of molecular vulnerabilities in glioblastoma, treatment options remain limited, and molecular assays guided by genomic and expression profiling to in...
Autores principales: | Chadwick, Michelle, Yang, Chen, Liu, Liqiong, Gamboa, Christian Moya, Jara, Kelly, Lee, Howon, Sabaawy, Hatem E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7393526/ https://www.ncbi.nlm.nih.gov/pubmed/32731171 http://dx.doi.org/10.1016/j.isci.2020.101365 |
Ejemplares similares
-
Generation of glioblastoma patient-derived organoids and mouse brain orthotopic xenografts for drug screening
por: Gamboa, Christian Moya, et al.
Publicado: (2021) -
Optimized 3D Culture of Hepatic Cells for Liver Organoid Metabolic Assays
por: Gamboa, Christian Moya, et al.
Publicado: (2021) -
Patient derived organoids in prostate cancer: improving therapeutic efficacy in precision medicine
por: Pamarthy, Sahithi, et al.
Publicado: (2021) -
Utility of Glioblastoma Patient-Derived Orthotopic Xenografts in Drug Discovery and Personalized Therapy
por: Patrizii, Michele, et al.
Publicado: (2018) -
Personalized Medicine Approaches in Prostate Cancer Employing Patient Derived 3D Organoids and Humanized Mice
por: Bartucci, Monica, et al.
Publicado: (2016)